GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 3, Pages 799-809
Publisher
Wiley
Online
2013-11-15
DOI
10.1111/bph.12518
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Concise Guide to PHARMACOLOGY 2013/14: Overview
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Deletion of Glutamate Delta-1 Receptor in Mouse Leads to Enhanced Working Memory and Deficit in Fear Conditioning
- (2013) Roopali Yadav et al. PLoS One
- NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
- (2013) Melissa A. Snyder et al. Frontiers in Cellular Neuroscience
- Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
- (2012) C S Weickert et al. MOLECULAR PSYCHIATRY
- D-Cycloserine: An Evolving Role in Learning and Neuroplasticity in Schizophrenia
- (2012) D. C. Goff SCHIZOPHRENIA BULLETIN
- Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory
- (2011) Brandon G. Hillman et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- GABAergic interneuron origin of schizophrenia pathophysiology
- (2011) Kazu Nakazawa et al. NEUROPHARMACOLOGY
- NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis
- (2011) Gary Gilmour et al. NEUROPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Cortical disinhibition in the neonatal ventral hippocampal lesion model of schizophrenia: New vistas on possible therapeutic approaches
- (2011) Patricio O'Donnell PHARMACOLOGY & THERAPEUTICS
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
- (2010) Joshua T. Kantrowitz et al. BRAIN RESEARCH BULLETIN
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Structural Determinants of D-Cycloserine Efficacy at the NR1/NR2C NMDA Receptors
- (2010) S. M. Dravid et al. JOURNAL OF NEUROSCIENCE
- NMDA Receptor Ablation on Parvalbumin-Positive Interneurons Impairs Hippocampal Synchrony, Spatial Representations, and Working Memory
- (2010) Tatiana Korotkova et al. NEURON
- Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway
- (2010) Daisuke Ishii et al. NEUROSCIENCE LETTERS
- PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin
- (2010) José A. Larrauri et al. PSYCHOPHARMACOLOGY
- A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors
- (2010) Praseeda Mullasseril et al. Nature Communications
- Alterations of Cortical GABA Neurons and Network Oscillations in Schizophrenia
- (2010) Guillermo Gonzalez-Burgos et al. Current Psychiatry Reports
- NMDAR2B tyrosine phosphorylation regulates anxiety-like behavior and CRF expression in the amygdala
- (2010) Mina Delawary et al. Molecular Brain
- Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
- (2009) S. E. Kotermanski et al. JOURNAL OF NEUROSCIENCE
- Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
- (2009) Juan E Belforte et al. NATURE NEUROSCIENCE
- Effects of glutamate-related drugs on marble-burying behavior in mice: Implications for obsessive–compulsive disorder
- (2008) Nobuaki Egashira et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Chronic Psychoemotional Stress Impairs Cannabinoid-Receptor-Mediated Control of GABA Transmission in the Striatum
- (2008) S. Rossi et al. JOURNAL OF NEUROSCIENCE
- NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: Application of laser microdissection technique
- (2008) Dong Xi et al. JOURNAL OF NEUROSCIENCE METHODS
- Frontal–striatal–thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating
- (2008) Erin A. Hazlett et al. NEUROIMAGE
- Involvement of Pallidotegmental Neurons in Methamphetamine- and MK-801-Induced Impairment of Prepulse Inhibition of the Acoustic Startle Reflex in Mice: Reversal by GABAB Receptor Agonist Baclofen
- (2008) Sawako Arai et al. NEUROPSYCHOPHARMACOLOGY
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
- (2008) John E. Lisman et al. TRENDS IN NEUROSCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More